Fusion Pharmaceuticals Inc Company Overview

Fusion Pharmaceuticals Inc logo
Fusion Pharmaceuticals Inc
Fusion Pharmaceuticals Inc primary media

About Fusion Pharmaceuticals Inc

Fusion Pharmaceuticals (NASDAQ:FUSN) is a company focused on the development and commercialization of targeted alpha therapies (TATs) for treating cancer. This innovative approach aims to deliver highly potent alpha-emitting isotopes directly to tumor cells, minimizing damage to surrounding healthy tissue. Their pipeline includes several projects in various stages of development, aiming to address various types of cancers with unmet medical needs. Fusion Pharmaceuticals is committed to advancing its technologies and expanding its portfolio through strategic partnerships, research collaborations, and acquisitions to improve treatment outcomes for cancer patients worldwide.

What is Fusion Pharmaceuticals Inc known for?

Snapshot

2014
Year founded
117
Employees
Hamilton, Canada
Head office
Loading Map...

Operations

All Locations
Hamilton, CA

Produtos e/ou serviços de Fusion Pharmaceuticals Inc

  • Targeted alpha therapies (TATs) designed to treat a variety of cancers by delivering alpha particle emitting isotopes directly to tumor cells.
  • FPI-1434, a product in development for the treatment of tumors expressing IGF-1R, utilizing alpha-emitting isotope Actinium-225.
  • FPI-1966, aimed at treating FGFR3-expressing tumors, including bladder and other cancers, by utilizing the alpha-emitting isotope Actinium-225.

equipe executiva do Fusion Pharmaceuticals Inc

  • Dr. John F. Valliant Ph.D.Founder, CEO & Director
  • Mr. John J. Crowley CPACFO & Compliance Officer
  • Dr. Eric Burak Ph.D.Chief Technology Officer
  • Mr. Mohit RawatPresident & Chief Business Officer
  • Dr. Christopher Paul Leamon Ph.D.Chief Scientific Officer
  • Ms. Amanda CraySenior Director of Investor Relations & Corporate Communications
  • Ms. Maria D. StahlChief Legal Officer
  • Mr. Eric S. Hoffman Ph.D.Senior Vice President of Business Development
  • Dr. Cara Ferreira Ph.D.Chief of Staff
  • Dr. Joanne SchindlerExecutive Vice President of Medical Director & Clinical Development

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.